MedPath

Lumicitabine

Generic Name
Lumicitabine
Brand Names
-
Drug Type
Small Molecule
Chemical Formula
C18H25ClFN3O6
CAS Number
1445385-02-3
Unique Ingredient Identifier
BNW5PQ52G1
Background

Lumicitabine is under investigation in clinical trial NCT03010059 (A Study to Assess the Relative Bioavailability of JNJ64041575 Administered as 2 Different New Concept Formulations (Oral Suspension and Tablet) Compared to Their Respective Current Formulations, and to Assess the Effect of Food on the Pharmacokinetics of the 2 New Concept Formulations).

Associated Conditions
-
Associated Therapies
-
© Copyright 2025. All Rights Reserved by MedPath